Free Trial

SteelPeak Wealth LLC Acquires Shares of 3,519 HCA Healthcare, Inc. (NYSE:HCA)

HCA Healthcare logo with Medical background

SteelPeak Wealth LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,519 shares of the company's stock, valued at approximately $1,056,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of HCA. FMR LLC grew its position in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company's stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the last quarter. Meritage Group LP acquired a new stake in HCA Healthcare in the 3rd quarter worth about $150,548,000. Canoe Financial LP raised its holdings in HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company's stock valued at $69,513,000 after acquiring an additional 231,492 shares during the last quarter. Holocene Advisors LP boosted its holdings in HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company's stock valued at $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Finally, Nordea Investment Management AB raised its position in HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company's stock valued at $253,020,000 after purchasing an additional 193,075 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company's stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HCA shares. Oppenheimer increased their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a report on Monday, October 28th. Royal Bank of Canada dropped their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Finally, TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $382.19.

Check Out Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $333.91 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock's fifty day moving average is $313.18 and its two-hundred day moving average is $353.09. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a market capitalization of $84.58 billion, a PE ratio of 14.99, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the business earned $5.90 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 21.75 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.86%. HCA Healthcare's dividend payout ratio is 11.85%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines